Target intelligence / Profile preview

Sterigmatocystin 7-O-methyltransferase (OmtA) (OmtA)

Target
OmtA
Molecular classification
Enzyme, Transferase, Methyltransferase
01

Overview

Sterigmatocystin 7-O-methyltransferase, commonly referred to as O-methyltransferase A (OmtA), is a vital enzyme in the aflatoxin biosynthetic pathway of fungi such as Aspergillus flavus and Aspergillus parasiticus [1, 2]. It catalyzes the S-adenosyl-L-methionine (SAM)-dependent methylation of sterigmatocystin (ST) to form O-methylsterigmatocystin (OMST), a key penultimate step in the production of the potent hepatocarcinogen aflatoxin B1 [2, 14]. Due to the severe health impacts of aflatoxins, which include acute toxicosis and a high risk of hepatocellular carcinoma in humans, OmtA is considered a significant target for anti-aflatoxigenic intervention [1, 14]. Current research focuses on discovering small-molecule inhibitors like piperlonguminine and blasticidin S, and employing gene-silencing techniques like Host-Induced Gene Silencing (HIGS) to reduce toxin levels in crops [2, 4]. By targeting this enzymatic step, biotechnologists aim to block the synthesis of toxic metabolites while preserving the ecological niche of the fungus [2]. Safety and efficacy evaluations are crucial to ensure that inhibitors do not interfere with host methyltransferase systems or cause broader environmental damage [1, 12].

Other names
O-methyltransferase AOmt-AaflPSterigmatocystin methyltransferaseSterigmatocystin 7-O-methyltransferase
02

Mechanism of action

Inhibition of the enzymatic conversion of sterigmatocystin to O-methylsterigmatocystin in the aflatoxin biosynthetic pathway [1, 2].

03

Biological functions

Secondary metabolismAflatoxin biosynthesis
04

Disease associations

CancerAflatoxicosisInfection
05

Safety considerations

Potential for cross-reactivity with human methyltransferasesImpact on non-target fungal species in the soil microbiomeSelection for resistant fungal strains
06

Interacting drugs

Piperlonguminine

3 more in the full profile.

07

Biomarkers

Aflatoxin B1SterigmatocystinO-methylsterigmatocystin

Beyond the preview

Go deeper on Sterigmatocystin 7-O-methyltransferase (OmtA) (OmtA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterigmatocystin 7-O-methyltransferase (OmtA) (OmtA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call